Results 151 to 160 of about 1,440 (186)
Dysferlin and Animal Models for Dysferlinopathy
Dysferlin (DYSF) is involved in the membrane-repair process, in the intracellular vesicle system and in T-tubule development in skeletal muscle. It interacts with mitsugumin 53, annexins, caveolin-3, AHNAK, affixin, S100A10, calpain-3, tubulin and dihydropyridine receptor.
Takeshi Izawa
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Neurology India, 2008
Dysferlinopathies encompass a large variety of neuromuscular diseases characterized by the absence of dysferlin in skeletal muscle and an autosomal recessive mode of inheritance. So far, three main phenotypes have been reported: Miyoshi myopathy (MM), limb girdle muscular dystrophy type 2B (LGMD 2B), and distal myopathy with anterior tibial onset (DMAT)
Urtizberea, J. Andoni +5 more
openaire +2 more sources
Dysferlinopathies encompass a large variety of neuromuscular diseases characterized by the absence of dysferlin in skeletal muscle and an autosomal recessive mode of inheritance. So far, three main phenotypes have been reported: Miyoshi myopathy (MM), limb girdle muscular dystrophy type 2B (LGMD 2B), and distal myopathy with anterior tibial onset (DMAT)
Urtizberea, J. Andoni +5 more
openaire +2 more sources
“Boule du biceps” in dysferlinopathy
Neurology, 2020Eymard et al.1 first described “boule du biceps” (bulging of biceps), a ball-like appearance caused by the selective atrophy of the distal half of the biceps brachii (BB) muscle, in patients with dysferliniopathy. This sign is also known as biceps lump.
Rasha, El Sherif +2 more
openaire +2 more sources
2011
Dysferlin is a sarcolemmal protein that plays an important role in patching defects in skeletal membrane by regulating vesicle fusion with the sarcolemma. Mutations in the dysferlin gene can lead to a variety of clinical phenotypes. Affected individuals usually present with early involvement of the posterior calf muscles (Miyoshi myopathy) in their ...
Anthony A, Amato, Robert H, Brown
openaire +2 more sources
Dysferlin is a sarcolemmal protein that plays an important role in patching defects in skeletal membrane by regulating vesicle fusion with the sarcolemma. Mutations in the dysferlin gene can lead to a variety of clinical phenotypes. Affected individuals usually present with early involvement of the posterior calf muscles (Miyoshi myopathy) in their ...
Anthony A, Amato, Robert H, Brown
openaire +2 more sources
The earliest pathologic alterations in dysferlinopathy
Neurology, 2001Dysferlinopathies are associated with proximal or distal muscular dystrophy. Dysferlin immunolocalizes to the muscle fiber periphery but does not associate with the dystrophin--glycoprotein complex; its function in humans, and the mechanism by which it causes muscle fiber injury, are not known.
D, Selcen, G, Stilling, A G, Engel
openaire +2 more sources
Dysferlinopathy in Iran: Clinical and genetic report
Journal of the Neurological Sciences, 2015Dysferlinopathy is caused by a very wide range of autosomal recessively inherited mutations of the Dysferlin gene. It causes a spectrum of muscle diseases including limb-girdle muscular dystrophy (LGMD) 2B and Miyoshi myopathy (MM). We describe the clinical course and mutational analyses of 15 Iranian patients with dysferlinopathy from 9 different ...
Nicolas Levy +2 more
exaly +3 more sources
Dysferlinopathy associated with rigid spine syndrome
Neuropathology, 2004Dysferlinopathy and rigid spine syndrome occurring in a 50‐year‐old man is reported. The patient noticed stiffness of knee and ankle joints, which gradually extended to neck, wrist and elbow joints leading to difficulty in anterior flexion. Muscular weakness and wasting of the lower extremities had developed since age 40, accompanied by a ...
Toshiko, Nagashima +11 more
openaire +2 more sources
Prospects for the Etiotropic Treatment of Dysferlinopathy
Annals of the Russian academy of medical sciences, 2021Dysferlinopathies belong to a phenotypically heterogeneous group of neuromuscular diseases caused by mutations in the DYSF gene, which disrupt the expression of dysferlin protein in human skeletal muscle cells. These pathologies are of an autosomal recessive inheritance pattern, their prevalence is 1: 200000.
Alisa V. Ivanova +2 more
openaire +1 more source
A new phenotype of dysferlinopathy with congenital onset
Neuromuscular Disorders, 2009We report two patients with a new phenotype of dysferlinopathy presenting as congenital muscular disease. Both patients showed weakness in proximal lower limbs and neck flexor muscles at birth. The presence of normal CK levels during the first years should be noted.
Paradas, C +8 more
openaire +3 more sources
A case of dysferlinopathy presenting choreic movements
Movement Disorders, 2006AbstractMutations in the dysferlin gene cause limb–girdle muscular dystrophy type 2B (LGMD2B). The involvement of the central nervous system in dysferlinopathy has not been described. We describe the clinical features of a patient with LGMD2B associated with dysferlin mutations (homozygous G3370T) who presented progressive choreic movements.
Toshiaki, Takahashi +9 more
openaire +2 more sources

